---
schema_version: "secwatch.filing_event.v1"
accession: "0000070318-24-000037"
form_type: "8-K"
ticker: "THC"
cik: "0000070318"
company_name: "TENET HEALTHCARE CORP"
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:37:04.159612+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tenet Q2 Net Income $259M, Adj EPS $2.31; Raises FY 2024 EBITDA, FCF Outlook

## Summary
- Q2 net income $259M ($2.64 diluted EPS), up from $123M ($1.15) YoY; adjusted EPS $2.31.
- Consolidated Adjusted EBITDA $945M (+12.1% YoY); Ambulatory Care EBITDA $447M (+20.8%).
- New $1.5B share repurchase authorization; completed prior $1B program with 4.8M shares bought in H1 2024.
- FY 2024 Adjusted EBITDA guidance raised to $3.825-3.975B (+$300M); FCF outlook raised to $1.1-1.35B (+$150M).
- Same-hospital admissions up 5.2% vs Q2 2023; same-facility ambulatory surgical cases +0.2% with net rev/case +6.8%.

## SEC filing metadata
- accession: 0000070318-24-000037
- form_type: 8-K
- ticker: THC
- cik: 0000070318
- company_name: TENET HEALTHCARE CORP
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70318/000007031824000037/0000070318-24-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70318/000007031824000037/thc-20240724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000070318-24-000037
- JSON: https://secwatch.observer/filing/0000070318-24-000037.json
- Plain text: https://secwatch.observer/filing/0000070318-24-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.